.

Defense Digest

Federal Court Cautions Lawyers on Pleading Affirmative Defenses

Defense Digest, Vol. 27, No. 4, September 2021

September 1, 2021

by Holli K. Archer

Key Points:

  • Affirmative defenses that do not give rise to a good faith basis to plead such defenses violate Federal Rule of Civil Procedure 11.
  • A court may impose sanctions for violating Federal Rule of Civil Procedure 11.
  • The Federal Rules of Civil Procedure give other options to filing an answer without a factual basis when there is not enough time to conduct an investigation.

It is common for lawyers to want plead any and all affirmative defenses in answers to complaints in order to prevent a waiver. However, the Federal Rules of Civil Procedure do not allow this tactic or the assertion of boilerplate affirmative defenses. Specifically, Rule 11 of the Federal Rules of Civil Procedure states that a lawyer who presents to the court a “pleading, written motion, and other paper” confirms “to the best of the person’s knowledge, information, and belief, formed after an inquiry reasonable under the circumstances” that the “claims defenses and other legal contentions are warranted by existing law” and that the “factual contentions have evidentiary support after a reasonable opportunity for further investigation or discovery.” Fed. R. Civ. P. 11(b)(2), (3). If Rule 11 is violated, a lawyer may be sanctioned by the court. See Fed. R. Civ. P. 11(c)(1), (3).

In Greenspan v. Platinum Healthcare Group, LLC, 2021 WL 978899 (E.D. Pa. Mar. 16, 2021), the court imposed sanctions under Rule 11 by striking affirmative defenses from an answer, without prejudice. The case arose out of a fall suffered by Ruth Greenspan at a Platinum Healthcare facility due to the alleged negligent care provided by the facility, which caused Ms. Greenspan’s death. According to the court’s opinion, a complaint was filed by the Administrator of the decedent’s estate against Platinum Healthcare and others on November 23, 2020. The plaintiff served Platinum Healthcare on December 7, 2020, which would have made their answer due on December 28, 2020. However, Platinum Healthcare did not file an answer by the deadline. Then, on January 28, 2021, the court issued an order directed to the plaintiff, stating that if he did not seek a default by February 22, 2021, the case would be dismissed for failure to prosecute. Thereafter, on February 22, 2021, Platinum Healthcare filed an answer, asserting 25 affirmative defenses, including: lack of personal jurisdiction, lack of subject matter jurisdiction, the plaintiff’s execution of a jury waiver or an arbitration agreement, comparative or contributory negligence, assumption of risk, the statute of limitations, res judicata or collateral estoppel, and accord and satisfaction.

The court opined that the defendant failed to aver any allegations or provide any facts or evidence that would give rise to a good faith basis to plead the defenses asserted. Rather, the court found that they were raised to prevent waiver. The court held that the defendant’s affirmative defenses violated Rule 11 because they were pleaded with conditional language, signaling to the court that the defendant did not have evidentiary support as to the assertion of its defenses.

The court went on to further reject two of Platinum Healthcare’s arguments in its memorandum defending its answer. First, Platinum Healthcare stated that the assertion of the above-named affirmative defenses was supported through experience in defending other similarly situated health care providers in similar cases, as these affirmative defenses often arise throughout the course of discovery. The court opined that Rule 11 does not allow counsel to merely “assert defenses that might apply based on experience in a particular field. It only allows affirmative defenses that the evidence supports in this case.” Second, Platinum Healthcare attempted to further defend its answer by stating that their counsel had became aware of the case just 12 days before filing the answer and that its investigation of the facts was reasonable given the short amount of time it had to file its answer. The court stated that Rule 11 allows for a bit of factual inaccuracy, but “a short time to investigate does not obviate the requirement that a lawyer have a good faith basis to contend that there is an evidentiary basis for each affirmative defense that is in an answer.” Therefore, the court concluded that Platinum Healthcare did not meet that requirement.

The court opined that stating such boilerplate affirmative defenses is harmful and magnifies discovery in cases, making it harder for them to come to a resolution. It compels a plaintiff’s lawyer to serve discovery to determine the factual basis for each affirmative defense that can result in motions to withdraw certain defenses—which tacks unnecessary time onto the litigation—for affirmative defenses that should not have been asserted to begin with.

The court reminded lawyers that there are options to comply with Rule 11, such as asking plaintiff’s counsel and/or the court for a brief extension to file an answer in order to conduct a reasonable investigation of the facts. Also, an answer without affirmative defenses can be filed and then amended pursuant to Fed. R. Civ. P. 15(a)(1)(A). The court even goes further to state that Federal Rule of Civil Procedure 15(a)(2) orders that courts “freely give leave when justice so requires.” With these options in mind, the court stated that “the answer is never to file an answer—or any other pleading—without a factual basis.”

For a defense lawyer, it is important when asserting affirmative defenses in federal court that he or she have a good faith basis to plead such defenses. Otherwise, one might find oneself in the unfortunate situation of defending a Rule 11 motion.

*Holli is an associate in our King of Prussia, Pennsylvania, office. She can be reached at 610.354.8258 or hkbott@mdwcg.com.

Defense Digest, Vol. 27, No. 4, September 2021 is prepared by Marshall Dennehey Warner Coleman & Goggin to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. ATTORNEY ADVERTISING pursuant to New York RPC 7.1. © 2021 Marshall Dennehey Warner Coleman & Goggin. All Rights Reserved. This article may not be reprinted without the express written permission of our firm. For reprints, contact tamontemuro@mdwcg.com.

Firm Highlights

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict. 

Thought Leadership

Congress Passes Financial Exploitation Prevention Act

On June 25, 2026, the House passed the Financial Exploitation Prevention Act of 2025 (“the Act”) by a vote of 414 to 2. The Act allows financial advisors and firms to delay suspicious transactions regarding the accounts of clients who are 65 or older, if they believe financial exploitation has occurred or is about to take place. With the advancement of technology and AI, the House’s overwhelming bipartisan passage of the Financial Exploitation Prevention Act represents an important step in strengthening the financial industry’s ability to combat the growing threat of elder financial exploitation. The Act recognizes what advisors have long known that financial professionals are often the first to detect suspicious behavior but have historically lacked clear legal authority to intervene before irreversible financial harm occurs. From the industry’s perspective, the bill accomplishes several important objectives, including the following: (1) Provides a practical “pause button” by allowing financial professionals to temporarily delay certain transaction requests when there is a reasonable belief that a senior or vulnerable adult is being financially exploited; (2) Empowers financial professionals to act by providing greater certainty that firms can act in good faith to protect clients without unnecessary legal risk; and (3) Strengthens investor protection without sacrificing client rights by allowing temporary delays based on a reasonable suspicion of exploitation, which is intended only to allow additional review and not to deny clients access to their money indefinitely. In sum, the Financial Exploitation Prevention Act will equip financial professionals with practical, carefully tailored tools to stop suspected financial exploitation before client assets are lost. By allowing firms to temporarily delay suspicious transactions under defined circumstances, Congress is recognizing the critical role advisors play as the first line of defense against increasingly sophisticated fraud schemes. The Act strikes an appropriate balance between protecting vulnerable investors and preserving individual financial autonomy, while reinforcing collaboration among advisors, families, and law enforcement to combat financial exploitation. The bill now awaits Senate action.

Thought Leadership

SIU Gets a Boost: NJ Supreme Court Affirms Insurers' Right to Litigate, Not Arbitrate, Fraud Claims

In a significant win for insurers' Special Investigation Units, the New Jersey Supreme Court clarified that statutory insurance fraud and racketeering claims may proceed in court rather than through PIP arbitration. At issue was whether insurance fraud claims brought under New Jersey's Insurance Fraud Prevention Act (IFPA) and the state's Anti-Racketeering Act (NJ RICO) are subject to mandatory arbitration under the Automobile Insurance Cost Reduction Act’s (AICRA) PIP dispute-resolution framework. Allstate had sued a network of medical practices, physicians, and related corporate entities, alleging a scheme to extract more than $1.7 million in PIP benefits through fraudulent and misleading billing. The trial court dismissed Allstate's complaint and compelled arbitration, reading AICRA's arbitration clause — which covers "any dispute regarding the recovery of... benefits" under PIP coverage, N.J.S.A. 39:6A-5.1(a) — as sweeping in fraud and racketeering claims along with routine benefit disputes. The Supreme Court affirmed the Appellate Division's reversal, adopting Judge Gilson's opinion below (480 N.J. Super. 566 (App. Div. 2025)) as its own reasoning. The Court held that IFPA and RICO claims fall outside the scope of AICRA's PIP arbitration mechanism because that "streamlined and specialized" process cannot grant the relief those statutes contemplate — treble damages, injunctive relief, broad discovery, and joinder of third parties — and because arbitrators lack authority to award compensatory or treble damages to an insurer. The Court also rejected the argument that Allstate's own Decision Point Review Plans independently compel arbitration, finding those plan provisions no broader than AICRA's own arbitration clause. Notably, the Court expressly disagreed with the Third Circuit's contrary holding in GEICO v. Mt. Prospect Chiropractic Center, 98 F.4th 463 (3d Cir. 2024), concluding it is not bound by that federal interpretation of New Jersey law. Insurers retain the right to pursue IFPA and RICO claims in the Law Division, with a jury trial. For SIU units and NJ insurance carriers, this decision is a significant win: it forecloses defense clinics' primary procedural tool for shunting fraud investigations into limited-scope PIP arbitration, where treble damages, RICO relief, and meaningful discovery were never realistically available. Carriers building cases against fraudulently structured clinics, straw-owned practices, or coordinated billing networks can now proceed with confidence that a well-pleaded IFPA/RICO complaint stays in the Law Division rather than being diverted to arbitration on a motion to compel. Practically, this strengthens SIU's leverage in settlement negotiations, preserves civil discovery tools (subpoenas, depositions, joinder of related corporate entities) critical to unwinding complex ownership and referral schemes, and resolves the split with the Third Circuit in favor of NJ insurers — at least as a matter of state law. Expect increased reliance on IFPA civil actions, rather than PIP arbitration demands, as SIU's primary enforcement vehicle going forward.

Thought Leadership

New Jersey Expands Family Leave Protections Effective July 17, 2026

On January 17, 2026, Governor Murphy signed into law legislation expanding the New Jersey Family Leave Act (NJFLA). Beginning July 17, 2026, significant amendments to the NJFLA will expand job-protected family leave to smaller businesses and more employees across the state. The new law broadens coverage by lowering the threshold for private employers from 30 employees to 15 employees, meaning many smaller businesses will now be subject to the NJFLA. Employees of state and local government agencies will continue to be covered regardless of the size of the employer. The amendments also make it easier for employees to qualify for leave. Under the revised law, an employee will be eligible after three months of employment and at least 250 hours worked during the preceding 12 months, replacing the previous requirement of 12 months of employment and 1,000 hours worked. Currently, New Jersey's Temporary Disability Insurance (TDI) and Family Leave Insurance (FLI) programs provide eligible employees with wage replacement while they are on leave but do not independently guarantee job protection. The recent amendments to the New Jersey Family Leave Act (NJFLA) expand these protections by extending job-protected leave to additional employees. Under the amended law, employees receiving TDI or FLI benefits may be entitled to return to the same position they held before taking leave, or to an equivalent position with the same seniority, status, pay, and benefits. Although the legislation also states that it does not expand or modify an employee's reinstatement rights under the NJFLA, the amendments appear to provide job protection to eligible employees receiving TDI or FLI benefits without requiring them to separately satisfy the eligibility requirements of the NJFLA or the federal Family and Medical Leave Act (FMLA). As a result, some employees may be entitled to longer periods of job-protected leave than were previously available under existing law. With these amendments, New Jersey continues to strengthen workplace protections by expanding access to job-protected family leave for eligible employees. These changes significantly expand access to job-protected family leave and may require employers to update their leave policies, employee handbooks, and HR practices. Notably, employers who were previously not required to administer NJFLA may need to amend their policies and/or create new protocols to come into compliance with the NJFLA. Failure to do so would prove costly, as the penalties for non-compliance are significant.